NCT04530786View on ClinicalTrials.gov

Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies Beyond the Season

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

Influenza

Interventions

DRUG

Influenza vaccine

"influenza vaccine 0.5 ml intramuscularly each season, antigens measured for 3 years following vaccination in:~* 2004-2005: A/Wyoming H3N2; B/Shanghai~* 2006-2007: A/New Caledonia H1N1~* 2007-2008: A/Solomon Islands; A/Wisconsin H3N2; B/Malaysia"

Trial Locations (1)

53792

University of Wisconsin, Madison

All Listed Sponsors

lead

University of Wisconsin, Madison

OTHER

NCT04530786 - Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies Beyond the Season | Biotech Hunter | Biotech Hunter